Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
Date:7/31/2012

otice of Compliance (approval) by Health Canada for XIAFLEX for the treatment of Dupuytren's contracture in adults with a palpable cord in Canada.  The Company's licensee, Actelion Pharmaceuticals Ltd., expects to make XIAFLEX available to patients in Canada in the first half of 2013.
  • In June 2012, Auxilium announced positive top-line results from both phase III trials of XIAFLEX for the treatment of Peyronie's disease (assuming we receive FDA approval).  XIAFLEX demonstrated statistically significant improvement in the co-primary endpoints of penile curvature deformity and patient-reported bother versus placebo.
  • In May 2012, the Company and GlaxoSmithKline LLC ("GSK") announced that they entered into an agreement for the co-promotion of Testim, which is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of testosterone.  GSK began promoting Testim using a sizeable established field sales force in the U.S. in mid-July 2012.
  • In May 2012, Auxilium and FCB I LLC ("FCB") announced that the United States Patent and Trademark Office issued U.S. Patent No. 8,178,518 covering, among other things, Testim 1% testosterone gel, marketed by Auxilium under license from FCB. This tenth Orange Book listed patent, which claims certain pharmaceutical compositions comprising testosterone, is expected to expire in April 2023.
  • In April 2012, Auxilium and FCB received a notice from Watson Laboratories, Inc. advising them of Watson's filing of an Abbreviated New Drug Application containing a Paragraph IV certification for testosterone gel.  In May 2012, Auxilium and FCB filed a lawsuit against Watson for infringement of Testim patents in the United States District Court for the District of New Jersey.
  • Second Quarter 2012 Financial Details 
    Total revenues for the three months ended June 30, 2012 were $78.2 million, an increase of 19% over the $65.9
    '/>"/>

    SOURCE Auxilium Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
    2. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
    3. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
    4. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
    5. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
    6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
    7. Jason Pharmaceuticals, Inc. Reaches Proposed Consent Agreement with FTC
    8. Avion Pharmaceuticals, LLC., Launches Prenate Mini
    9. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
    10. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
    11. Acella Pharmaceuticals, LLC, files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration for Topical Corticosteroids Lotion
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2014)... LOUIS , July 11, 2014 /PRNewswire/ ... device company, announced today the positive, cost-effective ... its innovative SPiNPerc™ procedure. The SPiNPerc endobronchial ... of a percutaneous approach to biopsy when ... Hospitals, patients and physicians experience positive financial ...
    (Date:7/10/2014)... NEWS, Virginia , 11. Juli ... Hersteller von Kameras für die molekulare ... (MBI/BSGI), hat heute die CE-Zulassung für ... dem CE-Zeichen kann Dilon das Produkt ... Vertriebsbereich auf den Großteil der europäischen ...
    (Date:7/10/2014)... , July 10, 2014  RESMED INC. (NYSE: ... fourth quarter and fiscal year ended June 30, 2014 results ... Exchange market close. A press release with ResMed,s results will ... company will host a webcast to discuss operating results and ... begin at 1:30 p.m. US Pacific Time and the live ...
    Breaking Medicine Technology:Veran Medical Publishes Lung Cancer Patient Management Study 2Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
    ... Group, an international generic pharmaceuticals company, today announced ... Extended-Release Tablets, 2mg, 4mg, 6mg, 8mg and 12mg, ... believes this is the first generic Requip® XL ... has commenced.   Requip® XL, 2mg, 4mg, ...
    ... Mass. and TORONTO, May 18, 2012 Generex ... members have joined the Scientific Advisory Board (SAB) ... the company,s AE37 breast cancer vaccine.  The following ... N. Hortobagyi, MD, FACP (University of Texas MD ...
    Cached Medicine Technology:Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets) 2Generex Augments Antigen Express Scientific Advisory Board 2Generex Augments Antigen Express Scientific Advisory Board 3Generex Augments Antigen Express Scientific Advisory Board 4
    (Date:7/12/2014)... 12, 2014 Floor-grade instrument ... 4.1 out of 5. This above-average score represents ... underpinning buyer negotiation power over the three years ... Son, “during the period, surging demand for healthcare ... with new product development, have placed upward pressure ...
    (Date:7/12/2014)... The largest pure occupational medicine company ... announce that it will be opening its fifth Georgia ... join four Atlanta-based Nova Medical Centers’ locations. The ... Bridge Road, and will be open from 8:30 a.m. ... Nova’s treatment philosophy of rapid return-to-work and decreased treatment ...
    (Date:7/11/2014)... Recently, MagicQuinceaneraDresses.com, the popular online supplier of special ... Quinceanera dresses . The company’s new items are ... without paying a large amount of money. They are ... , The company’s online shop has become a one ... outfits. In addition to exquisite Quinceanera dresses, it also ...
    (Date:7/11/2014)... (PRWEB) July 11, 2014 The American ... America’s 55 poison centers are commending Senator Bill Nelson ... Prevention Act of 2014 on July 10, 2014. Along ... Consumer Products Safety Commission (CPSC) to enact rules requiring ... consumers. , Senate co-sponsors of the bill ...
    (Date:7/11/2014)... reports that tickets to the Argentina vs. Germany World ... Brazil and Netherlands are in high demand. The ... at Estadio Nacional de Brasilia Mane Garrincha Brasila, Federal District. ... 13th at Estadio Jornalista Mario Filho - Estadio do Maracana, ... are guaranteed to be authentic and are covered by Ticket ...
    Breaking Medicine News(10 mins):Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Nova Medical Centers To Open New Facility in Augusta, Georgia 2Health News:Cheap Quinceanera Dresses Now Available At MagicQuinceaneraDresses.com 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 2Health News:AAPCC Issues Statement on the Introduction of the Child Nicotine Poison Prevention Act of 2014 3Health News:Argentina vs. Germany World Cup Finals Tickets & Brazil vs. Netherlands 3rd Place World Cup Tickets Are in Huge Demand 2
    ... Afghanistan and Nigeria is a polio-endemic country, according to ... the indigenous polio transmission, according to the report. // ... the virus has also been announced. ,The ... phase with the next-generation vaccines targeting the two surviving ...
    ... Kong from buying poultry from southern China. Chicken happens to be ... One seller at a market close to the border said Hong ... to make it easier to get them through the customs. ... of three from a village in the Shataukok border area were ...
    ... India for the sake of low priced cosmetic surgery. ... rhinoplasty, and breast improvements are very expensive. // Over ... every year. ,Recent figures released by ... breast enlargement topped the list of cosmetic operations performed ...
    ... affected as a result of snoring, according to research results ... Center // in Illinois. Most women are negatively affected by ... to divorces, according to the research. As many as 10 ... tense relationship develops between the couple when one of them ...
    ... on the verge of path breaking news that suggests ... // Reduced vitamin D levels in the mother ... onset of this disorder, according to the research report, ... long frozen Danish samples hold the clues that will help ...
    ... been raised against a Food Standards Agency advertisement, ... appropriate evidence. // An investigation was ordered following ... a salt-challenge had lowered their hypertension by consuming ... that examined the case stated that there was ...
    Cached Medicine News:Health News:More People Come To India For Cosmetic Surgery 2Health News:Sunny Side Up - Vitamin-D deficiency linked to Schizophrenia 2Health News:Government Advertisement Faces Criticism For Wrong Salt Claim 2
    ... the most useful features is the PupilFit ... mathematical analysis of the pupil images, producing ... instantaneously. The fitted circle is shown as ... proof that the measurement ismeaningful, and not ...
    Dual-sided, Interhemispheric Grid Electrode with 16 Contact Leads; Cortical Grid Electrode with 16 Contact Leads; Pediatric Grid Electrode with Flex Connector, 0.5 cm spacing...
    Ad-Techs Epidural Peg Electrodes feature a silicone-insulated titanium contact. To accommodate varying skull thicknesses, the post lengths range in length from 4 to 16 mm. The connecting lead wires e...
    ...
    Medicine Products: